{"id":2849,"date":"2023-03-31T11:16:30","date_gmt":"2023-03-31T11:16:30","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=2849"},"modified":"2023-03-31T11:23:16","modified_gmt":"2023-03-31T11:23:16","slug":"solascure-secures-13-4-million-in-series-b-funding-round","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/","title":{"rendered":"SolasCure Secures $13.4 Million In Series B Funding Round."},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-324.png\" alt=\"\" class=\"wp-image-2866\" width=\"147\" height=\"147\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-324.png 200w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-324-150x150.png 150w\" sizes=\"(max-width: 147px) 100vw, 147px\" \/><\/figure>\n\n\n\n<p>Cambridge, UK \u2013 <a href=\"https:\/\/solascure.com\/\">SolasCure<\/a>, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious wound care products significantly improve the health and well-being of patients, announced it has secured $13.4 million in a Series B funding round led by <a href=\"https:\/\/www.wealthclub.co.uk\/\">Wealth Club<\/a> with participation from <a href=\"http:\/\/senecapartners.com\/\">Seneca Partners<\/a> and <a href=\"https:\/\/www.brain-biotech.com\/\">BRAIN Biotech AG<\/a>. The funds will accelerate product development and enable the company to expand its reach into new markets.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/SolasCure-landing-page-photo_11zon.png\" alt=\"\" \/><\/figure>\n\n\n\n<p>\u201cWe are thrilled to have received this investment from such high-profile investors who share our vision in creating innovative products that improve patient outcomes,&#8221; said Sam Bakri, Founder of SolasCure. &#8220;This investment allows us to continue building on our success and progress towards bringing more life-changing products to market.\u201d<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/SolasCure-team-photo_11zon.png\" alt=\"\" \/><\/figure>\n\n\n\n<p>Founded by <a href=\"https:\/\/www.linkedin.com\/in\/sam-bakri-30a4863\/\">Sam Bakri<\/a>, SolasCure is a Cambridge-based biotechnology research company focused on developing advanced wound care products using biomimicry and evidence-based medicine principles. The company\u2019s flagship product is an advanced wound dressing designed to reduce healing time while providing superior protection against microbial contamination compared to traditional dressings. Additionally, the dressing can be applied quickly resulting in less disruption for patients during treatment sessions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious wound care products significantly improve the health and well-being of patients, announced it has secured $13.4 million in a Series B funding round led by Wealth Club with participation from Seneca Partners and BRAIN Biotech AG. The [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":2856,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SolasCure Secures $13.4 Million In Series B Funding Round. - Founder Lodge Latest News SolasCure Secures $13.4 Million In Series B Funding Round.<\/title>\n<meta name=\"description\" content=\"Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious wound care products significantly improve the health and well-being of patients, announced it has secured $13.4 million in a Series B funding round led by Wealth Club with participation from Seneca Partners and BRAIN Biotech AG.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SolasCure Secures $13.4 Million In Series B Funding Round. - Founder Lodge Latest News SolasCure Secures $13.4 Million In Series B Funding Round.\" \/>\n<meta property=\"og:description\" content=\"Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious wound care products significantly improve the health and well-being of patients, announced it has secured $13.4 million in a Series B funding round led by Wealth Club with participation from Seneca Partners and BRAIN Biotech AG.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-31T11:16:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-31T11:23:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/SolasCure-featured-image_11zon.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"531\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ucheezuma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ucheezuma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/\"},\"author\":{\"name\":\"ucheezuma\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\"},\"headline\":\"SolasCure Secures $13.4 Million In Series B Funding Round.\",\"datePublished\":\"2023-03-31T11:16:30+00:00\",\"dateModified\":\"2023-03-31T11:23:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/\"},\"wordCount\":192,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/\",\"name\":\"SolasCure Secures $13.4 Million In Series B Funding Round. - Founder Lodge Latest News SolasCure Secures $13.4 Million In Series B Funding Round.\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-03-31T11:16:30+00:00\",\"dateModified\":\"2023-03-31T11:23:16+00:00\",\"description\":\"Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious wound care products significantly improve the health and well-being of patients, announced it has secured $13.4 million in a Series B funding round led by Wealth Club with participation from Seneca Partners and BRAIN Biotech AG.\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SolasCure Secures $13.4 Million In Series B Funding Round.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\",\"name\":\"ucheezuma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"caption\":\"ucheezuma\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SolasCure Secures $13.4 Million In Series B Funding Round. - Founder Lodge Latest News SolasCure Secures $13.4 Million In Series B Funding Round.","description":"Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious wound care products significantly improve the health and well-being of patients, announced it has secured $13.4 million in a Series B funding round led by Wealth Club with participation from Seneca Partners and BRAIN Biotech AG.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/","og_locale":"en_US","og_type":"article","og_title":"SolasCure Secures $13.4 Million In Series B Funding Round. - Founder Lodge Latest News SolasCure Secures $13.4 Million In Series B Funding Round.","og_description":"Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious wound care products significantly improve the health and well-being of patients, announced it has secured $13.4 million in a Series B funding round led by Wealth Club with participation from Seneca Partners and BRAIN Biotech AG.","og_url":"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-03-31T11:16:30+00:00","article_modified_time":"2023-03-31T11:23:16+00:00","og_image":[{"width":1024,"height":531,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/SolasCure-featured-image_11zon.png","type":"image\/png"}],"author":"ucheezuma","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ucheezuma","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/"},"author":{"name":"ucheezuma","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3"},"headline":"SolasCure Secures $13.4 Million In Series B Funding Round.","datePublished":"2023-03-31T11:16:30+00:00","dateModified":"2023-03-31T11:23:16+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/"},"wordCount":192,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/","url":"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/","name":"SolasCure Secures $13.4 Million In Series B Funding Round. - Founder Lodge Latest News SolasCure Secures $13.4 Million In Series B Funding Round.","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-03-31T11:16:30+00:00","dateModified":"2023-03-31T11:23:16+00:00","description":"Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious Cambridge, UK \u2013 SolasCure, a biotechnology research company that leverages biomimicry and evidence-based medicine to develop fit-for-purpose, efficacious wound care products significantly improve the health and well-being of patients, announced it has secured $13.4 million in a Series B funding round led by Wealth Club with participation from Seneca Partners and BRAIN Biotech AG.","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/solascure-secures-13-4-million-in-series-b-funding-round\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"SolasCure Secures $13.4 Million In Series B Funding Round."}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3","name":"ucheezuma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","caption":"ucheezuma"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/2849"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=2849"}],"version-history":[{"count":2,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/2849\/revisions"}],"predecessor-version":[{"id":2868,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/2849\/revisions\/2868"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/2856"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=2849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=2849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=2849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}